Enhanced Recovery after Surgery in a Single High-Volume Surgical Oncology Unit: Details Matter

Table 4

ERAS versus non-ERAS (control) for test surgeon, 2013–2015.

Factor	ERAS% (number)	No ERAS% (number)	value	OR	value
Gender
Male	46.0 (40)	46.7 (43)	0.92
Female	54.0 (47)	53.3 (49)
Age
Median	62 (20–93)	63 (28–88)	0.41
Mean	61.4 (13.9)	63.1 (13.9)
Race
White	62.1 (54)	60.9 (56)	0.95
Black	34.5 (30)	34.8 (32)
Other	3.4 ()	4.3 ()
Diagnosis
Gastric cancer	4.8 ()	12.0 ()	0.35
Small bowel cancer	8.4 ()	5.4 ()
Colorectal cancer	24.1 ()	26.1 ()
Pancreatic cancer	21.7 ()	13.0 ()
Liver malignancies	12.1 ()	15.2 ()
Other abdominal	28.9 (24)	28.3 (26)
Charlson index
0–2	43.7 (38)	47.8 (44)	0.46
3–5	36.8 (32)	28.3 (26)
>5	19.5 (17)	23.9 (22)
Surgery
Pancreatectomy	27.6 (24)	14.1 (13)	0.064	2.07	0.069
Colectomy	12.6 (11)	12.0 (11)		Referent	Referent
Hepatic resection	12.6 (11)	20.7 (19)		1.30	0.58
Gastrectomy	4.6 (4)	12.0 (11)		1.07	0.91
Intestinal resection	16.1 (14)	21.7 (20)		1.23	0.64
Other abdominal	26.4 (23)	19.5 (18)		1.63	0.23
LOS
Median	5 (1–39)	6 (1–55)	0.024
Mean	6.2 (4.9)	9.6 (9.3)
Complications
Grade 0-I	67.8 (59)	54.4 (50)	0.064
Grade II–V	32.2 (28)	42.6 (42)
Cost
Median	18,716 (7,937–93,804)	24,395 (6,052–174,536)	0.029
Mean	21,674 (12,118)	30,380 (25,723)
Readmission	11.5 (10)	21.4 (19)	0.076
Mortality	0 (0)	3.3 (3)	0.044